Christopher M. Traudt, MD

Acting Assistant Professor
Neonatology

Dr. Traudt's research interests are focused on the effects of neuromodulating drugs on the developing brain. Premature and mature newborns are exposed to stress and pain while being cared for in the NICU. To try to alleviate the negative effects of pain and stress, drugs like morphine and lorazepam are commonly given. The safety of these drugs has not been rigorously studied. In collaboration with Dr. Juul, Dr. Traudt is investigating the acute and long-term effects of neonatal stress and its treatment with sedative and analgesic agents. Our goal is to effectively treat the pain and stress that neonates are exposed to during their stay in the NICU, while maximizing their brain development.